Terry Burkoth, Ph.D. Acting CEO and Business Advisory Board
|
Dr. Burkoth has 35 years experience of industrial
research and development experience. Areas of
specialization include guiding novel technologies,
including new molecular entities, drug delivery
systems, devices and diagnostics to
commercialization through all technical phases of
development, including the government regulatory
process. He was Chairman of the Board and Chief
Technology Officer of PowderChek Inc , Senior
Vice President and board member at PowderJect
Pharmaceuticals plc. He had been Vice President,
Product Development and a Principal Scientist at
Alza and Sandoz-Zoecon. He started
Scientist-Manager at Syva Corporation. Dr.
Burkoth earned a PhD in organic chemistry from
Stanford University and AB in chemistry from Ripon
College.